Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:sxuuboo
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
ARAMIS is an international Phase Ⅲ trial demonstrating the beneficial role of darolutamide,a novel anti-androgen that has been found to prolong metastasisfree survival in men with nonmetastatic castration-resistant prostate cancer.Darolutamide is a novel nonsteroidal androgen receptor antagonist that has unique structurally distinct properties with low blood-brain barrier penetration that was shown to improve metastasis-free survival by 22 months compared to placebo (40.4 months vs 18.4 months),reducing the risk of metastasis or death by 59%.Darolutamide also showed improvement in secondary and exploratory endpoints including progression-free survival,prolonged time to PSA progression,PSA response and time to initiating additional antineoplastic therapy,time to pain progression,and time to cytotoxic chemotherapy,but overall survival is not yet reached in either the darolutamide or the placeboarm.
其他文献
The testicular prosthesis can be an afterthought for providers when performing an orchiectomy for testicular cancer,torsion,atrophic testis,or trauma.However,data suggest that patients find the offer of a testicular prosthesis and counseling regarding pla
Testosterone (T) plays a crucial role in spermatogenesis because extremely low levels of intratesticular T lead to correspondingly low serum levels of total T (tT),severe disorders of spermatogenesis,and male sterility.However,there is little consensus on
Partial congenital hypogonadotropic hypogonadism (PCHH) is caused by an insufficiency in,but not a complete lack of,gonadotropin secretion.This leads to reduced testosterone production,mild testicular enlargement,and partial pubertal development.No studie
Peyronie\'s disease is a common condition resulting in penile deformity,psychological bother,and sexual dysfunction.Erectile dysfunction is one common comorbid condition seen in men with Peyronie\'s disease,and its presence significantly impacts treat
This study investigated the clinical activity of abiraterone plus prednisone in docetaxel-na(i)ve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer (mCRPC).A total of 146 patients with docetaxel-na(i)ve group (1
Autophagy and apoptosis have been regarded as important processes in the development of diabetic erectile dysfunction (DMED).Probucol is considered to have anti-apoptotic effects,but its relationship with autophagy has not been reported.The aim of this st
Lack of standardized,reproducible protocols and reference values is among the challenges faced when using new or upgraded versions of instruments in reproductive laboratories and flow cytometry.Terminal deoxynucleotidyl transferase dUTP nick end labeling
The first-line treatment options for high-risk prostate cancer (PCa) are definitive external beam radiotherapy (EBRT) with or without androgen deprivation therapy (ADT) and radical prostatectomy (RP) with or without adjuvant therapies.However,few randomiz
This study aimed to investigate the functional and morphological changes in the corpus cavernosum after cavernous nerve (CN)injury or neurectomy and then reveal whether treatment with the angiotensin Ⅱ Type 1 receptor antagonist Iosartan would improve ere
The syndrome of multiple morphological abnormalities of the sperm flagella (MMAF) is a specific kind of asthenoteratozoospermia with a mosaic of flagellar morphological abnormalities (absent,short,bent,coiled,and irregular flagella).MMAF was proposed in 2